Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC)

Journal
Journal for ImmunoTherapy of Cancer
ISSN
2051-1426
Date Issued
2019
Author(s)
Mehmet Altan
Vamsidhar Velcheti
Scott N. Gettinger
Roy S. Herbst
David L. Rimm
Kurt A. Schalper
Type
Resource Types::text::journal::journal article
Scopus ID
2-s2.0-85062609525
WoS ID
WOS:000460742000001
DOI
URL
URL Institutional Repository
Subjects
pembrolizumab

; 

association

; 

sensitivity

; 

nivolumab

; 

blockade

; 

tumors

; 

aged

; 

aged, 80 and over

; 

b7 antigens

; 

b7-h1 antigen

; 

biomarkers, tumor

; 

female

; 

fluorescent antibody technique

; 

humans

; 

kaplan-meier estimate

; 

lung neoplasms

; 

lymphocytes, tumor-infiltrating

; 

male

; 

middle aged

; 

neoplasm grading

; 

neoplasm staging

; 

prognosis

; 

retrospective studies

; 

small cell lung carcinoma

; 

v-set domain-containing t-cell activation inhibitor 1

; 

b7 h3 lymphocyte antigen

; 

cd20 antigen

; 

cd3 antigen

; 

cd8 antigen

; 

cytokeratin

; 

lymphocyte antigen

; 

programmed death 1 ligand 1

; 

unclassified drug

; 

v set domain containing t cell activation inhibitor 1

; 

b7 antigen

; 

cd274 protein, human

; 

cd276 protein, human

; 

programmed death 1 ligand 1

; 

tumor marker

; 

v set domain containing t cell activation inhibitor 1

; 

vtcn1 protein, human

; 

adult

; 

aged

; 

article

; 

cancer infiltration

; 

clinical feature

; 

female

; 

human

; 

human tissue

; 

immunofluorescence test

; 

immunostimulation

; 

immunotherapy

; 

lymphocytic infiltration

; 

major clinical study

; 

male

; 

overall survival

; 

priority journal

; 

protein expression

; 

protein targeting

; 

quantitative immunofluorescence test

; 

regulatory mechanism

; 

retrospective study

; 

small cell lung cancer

; 

tissue microarray

; 

tumor associated leukocyte

; 

cancer grading

; 

cancer staging

; 

fluorescent antibody technique

; 

genetics

; 

immunology

; 

kaplan meier method

; 

lung tumor

; 

metabolism

; 

middle aged

; 

mortality

; 

pathology

; 

prognosis

; 

small cell lung cancer

; 

tumor associated leukocyte

; 

very elderly